Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
4.01
0.31 (8.38%)
At close: May 01, 2025, 3:59 PM
4.04
0.75%
After-hours: May 01, 2025, 07:54 PM EDT

Silence Therapeutics Revenue

Silence Therapeutics reported an annual revenue of $43.26M, reflecting a 70.47% growth. For the quarter ending December 31, 2024, Silence Therapeutics generated $24.33M in revenue.
Revenue (ttm)
$43.26M
Revenue Growth
70.47%
Price / Sales Ratio
7.51
Revenue / Employee
$372.91K
Employees
116
Market Cap
189.37M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 43.26M +70.47%
Dec 31, 2023 25.38M +44.99%
Dec 31, 2022 17.5M +40.97%
Dec 31, 2021 12.41M +126.59%
Dec 31, 2020 5.48M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.